Fundraising FoxFlucas Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
EnClear Therapiesencleartherapies.cominFeb 2024
EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in
PartnerAshley Flucas· solo GP
Co-investors20/20 HealthCare Partners LLCDolby Family VenturesTachyon VenturesVU Venture PartnersAmgen VenturesBioverge+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.